Related Experiment Videos
Three drugs facing key patent expirations and potential generic entry from September to October 2020
1DrugPatentWatch.
Pharmaceutical Patent Analyst
|October 22, 2020
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Six drugs facing key patent expirations and potential generic entry from May to June 2022.
Pharmaceutical patent analyst·2022
Two drugs facing key patent expirations and potential generic entry from July to August 2020.
Pharmaceutical patent analyst·2020
Five drugs facing key patent expirations and potential generic entry from April to May 2020.
Pharmaceutical patent analyst·2020
Where Are Drugs Invented, and Why Does It Matter?
ACS medicinal chemistry letters·2017
Sulfopropanoic acid derivatives for treating neurodegenerative disorders: a patent spotlight.
Pharmaceutical patent analyst·2025
Trispecific anti-CLDN-18.2/CD3/CD28 antibodies for gastric cancer treatment.
Pharmaceutical patent analyst·2025
Trivalent bispecific anti-MSLN2/CD3 antibody for cancer treatment.
Pharmaceutical patent analyst·2025
Bispecific anti-CD38/CD28 antibodies for treatment of multiple myeloma.
Pharmaceutical patent analyst·2025
Proteolysis targeting chimeras (PROTACs) in oncology: a review of patents and regulatory considerations.
Pharmaceutical patent analyst·2025
Development in medicinal chemistry via oxadiazole derivatives: patent spotlight 2020-2024.
Pharmaceutical patent analyst·2025
Special Populations in Pivotal Clinical Trials: Eligibility and Supporting Evidence for Exclusion in EMA-Authorised Medicines.
Clinical pharmacology and therapeutics·2026
Pharmacogenomic and Medicinal Chemistry Perspectives on Off-label Drug Use.
Mini reviews in medicinal chemistry·2026
A SHAP-Informed Formal Feature Attribution Framework for Drug-Drug Interaction Risk in Large-Scale Claims Data.
Clinical and translational science·2026
Qualitative evidence of service user experiences and perspectives on long-acting injectable buprenorphine for opioid treatment - a scoping review.
The International journal on drug policy·2026
US postmarketed drug removals: Analysis of discontinued and withdrawn drugs.
The Journal of pharmacology and experimental therapeutics·2026
Examining Increased Ritalin and Adderall Use Among Low-Income People Who Use Drugs: Mixed Methods Study.
JMIR formative research·2026